4//SEC Filing
Gosebruch Henry O 4
Accession 0001610717-23-000290
CIK 0001885522other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 9:47 PM ET
Size
6.6 KB
Accession
0001610717-23-000290
Insider Transaction Report
Form 4
Gosebruch Henry O
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2023-09-19$12.62/sh+15,000$189,371→ 15,000 total(indirect: See Footnote)
Holdings
- 382,345
Common Stock
- 127,448(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.465 to $12.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F2]Shares held by HG4KYC TRUST, of which Reporting Person is trustee.
- [F3]Shares held by Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust, of which Reporting Person is trustee.
Documents
Issuer
Neumora Therapeutics, Inc.
CIK 0001885522
Entity typeother
Related Parties
1- filerCIK 0001659625
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 9:47 PM ET
- Size
- 6.6 KB